CASI Pharmaceuticals Revenue 2006-2019 | CASI

CASI Pharmaceuticals revenue from 2006 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
CASI Pharmaceuticals Annual Revenue
(Millions of US $)
2018 $
2017 $
2016 $
2015 $0
2014 $0
2013 $
2012 $1
2011 $2
2010 $4
2009 $5
2008 $7
2007 $7
2006 $7
2005 $6
CASI Pharmaceuticals Quarterly Revenue
(Millions of US $)
Q2 2019
Q1 2019
Q4 2018
Q3 2018
Q2 2018
Q1 2018
Q4 2017
Q3 2017
Q2 2017
Q1 2017
Q4 2016
Q3 2016
Q2 2016
Q1 2016
Q4 2015 $0
Q3 2015
Q2 2015 $0
Q1 2015 $0
Q4 2014
Q3 2014
Q2 2014
Q1 2014
Q4 2013
Q3 2013
Q2 2013
Q1 2013
Q4 2012
Q3 2012
Q2 2012
Q1 2012
Q4 2011 $2
Q3 2011
Q2 2011 $0
Q1 2011
Q4 2010 $4
Q3 2010
Q2 2010 $0
Q1 2010
Q4 2009 $2
Q3 2009 $4
Q2 2009
Q1 2009
Q4 2008 $4
Q3 2008 $4
Q2 2008
Q1 2008
Q4 2007 $4
Q3 2007 $4
Q2 2007
Q1 2007
Q4 2006 $4
Q3 2006 $3
Q2 2006
Q1 2006
Q4 2005 $4
Q3 2005 $1
Q2 2005 $1
Q1 2005 $0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.328B $0.000B
CASI Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on the acquisition, development and commercialization of proprietary therapeutics for the treatment of cancer and other diseases for the global markets, with a focus on China. The Company's products present antiangiogenic solutions to cancer, cardiovascular disease, and macular degeneration. CASI Pharmaceuticals Inc., formerly known as EntreMed, Inc., is headquartered in Rockville, Maryland.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $57.135B 35.19
Astellas Pharma (ALPMY) Japan $28.433B 13.55
Takeda Pharmaceutical (TAK) Japan $27.076B 8.45
Eisai (ESALY) Japan $14.552B 25.02
UCB SA (UCBJF) Belgium $14.267B 0.00
Merck (MKGAF) Germany $14.152B 19.31
Grifols, S.A (GRFS) Spain $13.827B 17.64
Ono Pharmaceutical (OPHLF) Japan $9.383B 20.06
Ionis Pharmaceuticals (IONS) United States $9.151B 19.74
Neurocrine Biosciences (NBIX) United States $8.956B 0.00
Sage Therapeutics (SAGE) United States $8.541B 0.00
IPSEN SA ADR (IPSEY) France $8.529B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.588B 9.99
Catalent (CTLT) United States $7.386B 29.24
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 19.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.781B 0.00
STADA ARZNEIMI (STDAF) Germany $5.547B 0.00
Orion OYJ (ORINY) Finland $5.275B 27.16
Hypermarcas (HYPMY) Brazil $5.064B 18.20
Nektar Therapeutics (NKTR) United States $3.719B 0.00
United Therapeutics (UTHR) United States $3.663B 0.00
FibroGen (FGEN) United States $3.635B 90.91
Evotec AG (EVTCY) Germany $3.420B 46.83
Taro Pharmaceutical Industries (TARO) Israel $3.238B 11.61
Tilray (TLRY) Canada $3.006B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.791B 64.00
PTC Therapeutics (PTCT) United States $2.533B 0.00
Portola Pharmaceuticals (PTLA) United States $2.128B 0.00
Xencor (XNCR) United States $2.058B 44.86
Zogenix (ZGNX) United States $1.852B 0.00
Heron Therapeutics (HRTX) United States $1.675B 0.00
USANA Health Sciences (USNA) United States $1.604B 16.08
CLINIGEN GP (CLIGF) United Kingdom $1.577B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.567B 57.01
Corcept Therapeutics (CORT) United States $1.511B 20.77
Ironwood Pharmaceuticals (IRWD) United States $1.510B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.376B 22.69
Radius Health (RDUS) United States $1.339B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.302B 0.00
Aerie Pharmaceuticals (AERI) United States $1.095B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.095B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.999B 4.45
Endo (ENDP) Ireland $0.951B 1.67
ArQule (ARQL) United States $0.934B 0.00
TherapeuticsMD (TXMD) United States $0.890B 0.00
Concordia (CXRXF) Canada $0.770B 0.00
Karyopharm Therapeutics (KPTI) United States $0.734B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.654B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.589B 0.00
Organogenesis Holdings (ORGO) United States $0.574B 0.00
Akebia Therapeutics (AKBA) United States $0.568B 0.00
Flexion Therapeutics (FLXN) United States $0.555B 0.00
Lannett Co Inc (LCI) United States $0.543B 5.72
Translate Bio (TBIO) United States $0.540B 0.00
ImmunoGen (IMGN) United States $0.508B 0.00
Aptorum Group (APM) China $0.491B 0.00
Dermira (DERM) United States $0.487B 0.00
Indivior (INVVY) United States $0.481B 1.74
Dova Pharmaceuticals (DOVA) United States $0.478B 0.00
Siga Technologies (SIGA) United States $0.469B 1.10
Innate Pharma SA (IPHYF) France $0.455B 0.00
ChemoCentryx (CCXI) United States $0.443B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.434B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.428B 19.44
Collegium Pharmaceutical (COLL) United States $0.416B 0.00
Harpoon Therapeutics (HARP) United States $0.392B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.370B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.347B 0.00
DURECT (DRRX) United States $0.336B 0.00
OptiNose (OPTN) United States $0.323B 0.00
Ardelyx (ARDX) United States $0.317B 0.00
CV Sciences (CVSI) United States $0.309B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.300B 0.00
Xeris Pharmaceuticals (XERS) United States $0.297B 0.00
Rafael Holdings (RFL) United States $0.291B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.282B 0.00
Recro Pharma (REPH) United States $0.268B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.267B 0.00
KalVista Pharmaceuticals (KALV) United States $0.263B 0.00
Concert Pharmaceuticals (CNCE) United States $0.260B 0.00
Molecular Templates (MTEM) United States $0.227B 0.00
Calithera Biosciences (CALA) United States $0.220B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.216B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.214B 0.00
CannTrust Holdings (CTST) Canada $0.212B 0.00
Ocular Therapeutix (OCUL) United States $0.206B 0.00
GlycoMimetics (GLYC) United States $0.202B 0.00
Nature's Sunshine Products (NATR) United States $0.190B 31.81
Generex Biotechnology (GNBT) United States $0.173B 0.00
Redhill Biopharma (RDHL) Israel $0.172B 0.00
Taiwan Liposome (TLC) Taiwan $0.161B 0.00
IMV INC (IMV) Canada $0.153B 0.00
MEI Pharma (MEIP) United States $0.142B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.140B 0.00
Cardiome Pharma (CORV) Canada $0.132B 0.00
ElectroCore (ECOR) United States $0.115B 0.00
Jounce Therapeutics (JNCE) United States $0.113B 0.00
Majesco Entertainment (PTE) United States $0.113B 0.00
Mast Therapeutics (SVRA) United States $0.111B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.108B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.105B 0.00
Neos Therapeutics (NEOS) United States $0.094B 0.00
Genocea Biosciences (GNCA) United States $0.094B 0.00
AgeX Therapeutics (AGE) United States $0.094B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.092B 0.00
Iterum Therapeutics (ITRM) Ireland $0.090B 0.00
Aquestive Therapeutics (AQST) United States $0.089B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.088B 0.00
MediWound (MDWD) Israel $0.086B 0.00
Champions Oncology (CSBR) United States $0.080B 690.00
RENEURON GP (RNUGF) United Kingdom $0.079B 0.00
Nivalis Therapeutics (ALPN) United States $0.079B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.076B 29.12
Entasis Therapeutics Holdings (ETTX) United States $0.075B 0.00
Natural Alternatives (NAII) United States $0.075B 7.47
Novan (NOVN) United States $0.075B 0.00
Lipocine (LPCN) United States $0.073B 0.00
Infinity Pharmaceuticals (INFI) United States $0.070B 0.00
Jaguar Animal Health (JAGX) United States $0.066B 0.00
Otonomy (OTIC) United States $0.066B 0.00
SCYNEXIS (SCYX) United States $0.062B 0.00
China SXT Pharmaceuticals (SXTC) China $0.061B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.059B 0.00
Capnia (SLNO) United States $0.057B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.056B 0.00
CTI BioPharma (CTIC) United States $0.050B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.048B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.047B 1.61
Dipexium Pharmaceuticals (PLXP) United States $0.046B 0.00
Forward Pharma (FWP) Denmark $0.046B 0.00
Aclaris Therapeutics (ACRS) United States $0.046B 0.00
India Globalization Capital (IGC) United States $0.044B 0.00
Melinta Therapeutics (MLNT) United States $0.044B 0.00
Mannatechorporated (MTEX) United States $0.039B 0.00
Opexa Therapeutics (ACER) United States $0.035B 0.00
Bio-Path Holdings (BPTH) United States $0.035B 0.00
PharmAthene (ALT) United States $0.034B 0.00
Biomerica (BMRA) United States $0.031B 0.00
ProPhase Labs (PRPH) United States $0.022B 0.00
IsoRay (ISR) United States $0.021B 0.00
Heat Biologics (HTBX) United States $0.020B 0.00
Achieve Life Sciences (ACHV) United States $0.019B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.018B 0.00
HANCOCK JAFFE (HJLI) United States $0.017B 0.00
Regulus Therapeutics (RGLS) United States $0.016B 0.00
Vical (BBI) United States $0.015B 0.00
Cyanotech (CYAN) United States $0.015B 0.00
Shineco (TYHT) China $0.014B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.013B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.013B 0.00
Onconova Therapeutics (ONTX) United States $0.013B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.011B 0.00
VAXART, INC (VXRT) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
RXi Pharmaceuticals (PHIO) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Flex Pharma (SLRX) United States $0.005B 0.00
Hemispherx BioPharma (AIM) United States $0.005B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00